As for other LHX members, early studies revealed that LHX2 promoted tumor cell proliferation in pancreatic ductal adenocarcinoma, and LHX4 facilitated the development of colorectal cancer, both via enhancing Wnt/TCF4/β-catenin pathway [7, 55]. The gene discussed is LHX2; the disease is pancreatic ductal adenocarcinoma.